Journal
NEUROBIOLOGY OF DISEASE
Volume 37, Issue 2, Pages 434-440Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2009.10.023
Keywords
Cannabidiol; Adenosine; Neuroprotection; Hypoxia-ischemia; Newborn; Mice
Categories
Funding
- CIBERNED [CB06/05/0089, CB06/05/1109]
- Ministerio de Ciencia e Innovacion Tecnologica [SAF2009-11847, SAF2007-61565]
- Fondo de Investigaciones Sanitarias [PI061085]
- Comunidad Autonoma de Madrid [S-SAL/0261/2006]
Ask authors/readers for more resources
To investigate the mechanisms involved in cannabidiol (CBD)-induced neuroprotection in hypoxic-ischemic (HI) immature brain, forebrain slices from newborn mice underwent oxygen and glucose deprivation in the presence of vehicle, or CBD alone or with selective antagonists of cannabinoid CB, and CB2, and adenosine A(1) and A(2) receptors. CBD reduced acute (LDH efflux to the incubation medium) and apoptotic (caspase-9 concentration in tissue) HI brain damage by reducing glutamate and IL-6 concentration, and TNF alpha, COX-2, and iNOS expression. CBD effects were reversed by the CB2 antagonist AM630 and by the A(2A) antagonist SCH58261. The A(1A) antagonist DPCPX only counteracted the CBD reduction of glutamate release, while the CB, antagonist SR141716 did not modify any effect of CBD. In conclusion, CBD induces robust neuroprotection in immature brain, by acting on some of the major mechanisms underlying HI cell death; these effects are mediated by CB2 and adenosine, mainly A(2A), receptors. (c) 2009 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available